MedTrace Logo

Cumulative Blood Pressure Load and Left Ventricular Mass

NCT05465746 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-07-20

No results posted yet for this study

Summary

Delay in the diagnosis of systemic arterial hypertension (SAH) causes morbid hypertensive status with target organ damage (TOD). Screening and surveillance of SAH used to be performed through self-measurement of blood pressure (SMBP) or routinary in clinic blood pressure measurement (CBPM).

It is essential to determine the correlation between the cumulative blood pressure load through ABPM and the left ventricular mass identified by three-dimensional transthoracic ultrasound (3D-TTE). We postulate a directly proportional and statistically significant association between cumulative blood pressure load and left ventricular mass (LVM).

Conditions

  • Arterial Hypertension

Interventions

DIAGNOSTIC_TEST

24-hour ambulatory blood pressure monitoring (ABPM)

Using a WatchBPO3 AFIB device (Microlife) placed around the left upper arm, BP measurements will be recorded every twenty minutes during the day and every thirty minutes at night, over a twenty-four-hour period. The device will automatically calculate the BP and the twenty-four-hour average BP, day, night, and cumulative BP load

DIAGNOSTIC_TEST

Three-dimensional transthoracic echocardiography

Using an EPIQ CVx (Philips) echocardiograph with an ultrasound sector transducer, 3D-TTE will be performed to assess the LVM index.

Sponsors & Collaborators

  • Instituto Ecuatoriano del Corazón

    lead OTHER

Principal Investigators

  • Patricia Delgado-Cedeño, MD · Instituto Ecuatoriano del Corazón

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-12-31
Completion
2023-02-28

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465746 on ClinicalTrials.gov